Table 1 Baseline clinical characteristics.

From: Dosimetric and radiobiological benefits of patient-specific respiratory motion management for liver tumor stereotactic body radiotherapy

Variables

Value (n = 23)

Age (years)

 

< 60

7 (30.4%)

> 60

16 (69.6%)

Gender

 

Male

16 (69.6%)

Female

7 (30.4%)

Tumor Diameter (cm)

 

< 5

14 (60.9%)

≥ 5

9 (39.1%)

Number of Tumors (n)

 

1

19 (82.6%)

> 1

4 (17.4%)

Diagnosis

 

Primary liver cancer

15 (65.2%)

Liver metastases

8 (30.4%)

Cholangiocarcinoma

1 (4.3%)

Interventional operation

 

Yes

14 (60.7%)

No

9 (39.1%)

Back to article page